SCHEMBL10029796

SCHEMBL10029796

CC(=O)c1c[nH]c2ncc(N)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.47
AXL P30530 5/20 0.45
HASPIN Q8TF76 1/20 0.40
PBRM1 Q86U86 1/20 0.40
SGK1 O00141 1/20 0.39
MAP3K7 O43318 1/20 0.39
TAB1 Q15750 1/20 0.39
NTRK1 P04629 1/20 0.39
ABL1 P00519 2/20 0.38
CYP3A4 P08684 1/20 0.38
MAP4K1 Q92918 1/20 0.38
MAP2K1 Q02750 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
AAK1 Q2M2I8 1/20 0.38
BRPF1 P55201 1/20 0.37
DYRK1A Q13627 2/20 0.37
DYRK1B Q9Y463 2/20 0.37
DAPK3 O43293 1/20 0.37
JAK2 O60674 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12146867 0.82 CYP2C19 (0.47) PIK3CAAXLHASPINPBRM1SGK1
SCHEMBL1516568 0.81 DYRK1A (0.48) PIK3CAAXLHASPINPBRM1SGK1
SCHEMBL17324586 0.81 BRAF (0.49) PIK3CAAXLHASPINPBRM1NTRK1
SCHEMBL12657427 0.81 PIK3CA (0.46) PIK3CAAXLHASPINPBRM1SGK1
SCHEMBL17324699 0.81 PIK3CA (0.46) PIK3CAAXLHASPINPBRM1SGK1
SCHEMBL10029802 0.79 MAP4K1 (0.46) AXLABL1CYP3A4MAP4K1AAK1
SCHEMBL24032679 0.78 MTNR1A (0.59) PIK3CAAXLHASPINNTRK1MAP2K1
SCHEMBL13627414 0.77 HASPIN (0.46) PIK3CAAXLHASPINPBRM1MAP3K7
SCHEMBL9906841 0.76 DYRK1A (0.43) PIK3CAAXLDYRK1ADYRK1B
SCHEMBL24296622 0.76 AXL (0.76) PIK3CAAXLSGK1AAK1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106069-B2 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2012-01-31 US disclosed
US-20100210476-A1 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them PFIZER ITALIA S.R.L. (IT) 2010-08-19 US disclosed
US-7728140-B2 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2010-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210476-A1 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them MAP3K6, MAP3K3, MAP3K1 PIK3CA 32/4885AXL 647/4885HASPIN 430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.